Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NTRA crawled time : 13:00 save search
Nature Medicine Publishes Two Studies Highlighting Signatera’s Clinical Utility in Patients with Gastrointestinal Malignancies
Published: 2024-01-25 (Crawled : 13:00) - biospace.com/
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: 0.59%
H: 0.64%
C: -2.09%
gastrointestinal
Natera to Report its Second Quarter 2023 Results on August 3rd
Published: 2023-07-27 (Crawled : 13:00) - biospace.com/
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: 1.23%
H: 0.4%
C: -4.99%
report results
New Natera Data to be Presented at the 2023 ASCO Annual Meeting in 13 Studies Across Multiple Cancer Types
Published: 2023-05-30 (Crawled : 13:00) - biospace.com/
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: 0.12%
H: 1.17%
C: -3.29%
asco cancer meeting
Natera Announces New Signatera™ MRD Data at 2023 AACR Annual Meeting
Published: 2023-04-14 (Crawled : 13:00) - biospace.com/
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: -0.86%
H: 1.93%
C: -0.39%
meeting
Foundation Medicine and Natera Announce the Launch of FoundationOne®Tracker Personalized Circulating Tumor DNA Monitoring Assay for Investigational Use and Early Access Clinical Use
Published: 2023-01-09 (Crawled : 13:00) - biospace.com/
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: 1.87%
H: 1.38%
C: -2.79%
foundationone tumor dna
Natera Supports Updated ISHLT Guidelines for the Care of Heart Transplant Patients
Published: 2022-12-22 (Crawled : 13:00) - biospace.com/
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: -1.73%
H: 4.73%
C: 4.68%
guidelines care heart
Natera Awarded National MRD Testing Contract by the U.S. Department of Veterans Affairs
Published: 2022-11-02 (Crawled : 13:00) - prnewswire.com
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: -0.41%
H: 2.73%
C: -2.22%
contract
Natera Earns Great Place to Work Certification™ for Second Consecutive Year
Published: 2022-08-25 (Crawled : 13:00) - biospace.com/
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: 2.54%
H: 0.13%
C: -1.16%
work year
Global Minimal Residual Disease (MRD) Testing Market to Reach $2.61 billion by 2027, Suggest a Latest BIS Research Study
Published: 2022-06-10 (Crawled : 13:00) - prnewswire.com
DGX | $128.08 1.72% 770K
|
Health Services
|
| O: -1.79%
H: 0.0%
C: 0.0%
LH M | $200.35 0.45% 250K
|
Health Services
|
| O: -4.59%
H: 0.0%
C: 0.0%
BIO | News | $279.16 -0.66% 200K
|
Health Technology
|
| O: -4.44%
H: 0.0%
C: 0.0%
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -4.2%
H: 0.0%
C: 0.0%
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: -7.01%
H: 0.0%
C: 0.0%
ICLR | $288.325 -1.2% 170K
|
Health Technology
|
| O: -3.06%
H: 0.0%
C: 0.0%
ADPT | $2.405 3.0% 1.1M
|
Commercial Services
|
| O: -6.61%
H: 0.0%
C: 0.0%
research disease market test
Natera Achieves Milestone of Enrolling First 1,000 Patients in its BESPOKE CRC Study
Published: 2022-03-11 (Crawled : 13:00) - prnewswire.com
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: -0.26%
H: 0.0%
C: 0.0%
one enroll milestone
Natera Validates Prospera™ With Quantification in Multi-Site, Prospective Trifecta Study
Published: 2021-11-03 (Crawled : 13:00) - biospace.com/
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: -4.41%
H: 0.87%
C: -1.24%
Natera Announces New Publication Validating Signatera® Velocity Metric to Improve Cancer Management
Published: 2021-10-11 (Crawled : 13:00) - biospace.com/
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: -2.71%
H: 1.19%
C: -1.7%
dating cancer
Natera Releases New Clinical Data at ESMO 2021 in Gastroesophageal Cancer and Uveal Melanoma
Published: 2021-09-17 (Crawled : 13:00) - biospace.com/
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: -0.11%
H: 0.0%
C: 0.0%
cancer
Natera Announces the Validation and Launch of the Prospera™ Heart Transplant Assessment Test
Published: 2021-08-31 (Crawled : 13:00) - biospace.com/
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: 0.66%
H: 0.34%
C: -1.8%
heart test
Natera to Participate in Upcoming Investor Conferences
Published: 2021-08-10 (Crawled : 13:00) - prnewswire.com
MS | News 0 d | $90.86 0.66% 4.7M
|
Finance
|
| O: 0.0%
H: 2.17%
C: 1.29%
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: -0.34%
H: 0.49%
C: -7.66%
conference
New Study Validates the Signatera® MRD Test and Demonstrates its Clinical Utility in Early-Stage Esophageal Cancer
Published: 2021-07-28 (Crawled : 13:00) - prnewswire.com
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: -0.04%
H: 3.49%
C: 1.88%
test cancer
Natera Reports Preliminary Second Quarter 2021 Results
Published: 2021-07-19 (Crawled : 13:00) - prnewswire.com
NTRA S | $84.04 -3.71% 1.3M
|
Health Services
|
| O: -1.46%
H: 0.05%
C: -4.69%
results
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.